191 related articles for article (PubMed ID: 23567503)
1. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Verslegers M; Lemmens K; Van Hove I; Moons L
Prog Neurobiol; 2013 Jun; 105():60-78. PubMed ID: 23567503
[TBL] [Abstract][Full Text] [Related]
2. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Van Hove I; Lemmens K; Van de Velde S; Verslegers M; Moons L
J Neurochem; 2012 Oct; 123(2):203-16. PubMed ID: 22862420
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology.
Chakrabarti S; Patel KD
Exp Lung Res; 2005; 31(6):599-621. PubMed ID: 16019990
[TBL] [Abstract][Full Text] [Related]
5. [Metalloproteinases activity (MMP-2, MMP-9) in distal stumps of rat sciatic nerves].
Woszczycka-Korczyńska I; Górka D; Matuszek I; Pietrucha-Dutczak M; Lewin-Kowalik J
Wiad Lek; 2005; 58(7-8):411-4. PubMed ID: 16425794
[TBL] [Abstract][Full Text] [Related]
6. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites.
Duchossoy Y; Horvat JC; Stettler O
Mol Cell Neurosci; 2001 Jun; 17(6):945-56. PubMed ID: 11414785
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.
Takács E; Nyilas R; Szepesi Z; Baracskay P; Karlsen B; Røsvold T; Bjørkum AA; Czurkó A; Kovács Z; Kékesi AK; Juhász G
Neurochem Int; 2010; 56(6-7):799-809. PubMed ID: 20303372
[TBL] [Abstract][Full Text] [Related]
8. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.
Chow AK; Cena J; Schulz R
Br J Pharmacol; 2007 Sep; 152(2):189-205. PubMed ID: 17592511
[TBL] [Abstract][Full Text] [Related]
9. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells.
Sbai O; Ferhat L; Bernard A; Gueye Y; Ould-Yahoui A; Thiolloy S; Charrat E; Charton G; Tremblay E; Risso JJ; Chauvin JP; Arsanto JP; Rivera S; Khrestchatisky M
Mol Cell Neurosci; 2008 Dec; 39(4):549-68. PubMed ID: 18817873
[TBL] [Abstract][Full Text] [Related]
10. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.
Sbai O; Ould-Yahoui A; Ferhat L; Gueye Y; Bernard A; Charrat E; Mehanna A; Risso JJ; Chauvin JP; Fenouillet E; Rivera S; Khrestchatisky M
Glia; 2010 Feb; 58(3):344-66. PubMed ID: 19780201
[TBL] [Abstract][Full Text] [Related]
11. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
[TBL] [Abstract][Full Text] [Related]
12. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
13. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.
Tomlinson ML; Garcia-Morales C; Abu-Elmagd M; Wheeler GN
Mech Dev; 2008; 125(11-12):1059-70. PubMed ID: 18684398
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.
Ranasinghe HS; Williams CE; Christophidis LJ; Mitchell MD; Fraser M; Scheepens A
Neuroscience; 2009 Jan; 158(2):732-44. PubMed ID: 18809469
[TBL] [Abstract][Full Text] [Related]
15. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
Hrabec E; Naduk J; Strek M; Hrabec Z
Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
[TBL] [Abstract][Full Text] [Related]
16. Ligation induced matrix-metalloproteinase-9 activity in peripheral frog nervous system.
Banasr S; Sbai O; Ould-Yahoui A; Gueye Y; Sakly M; Abdelmelek H
Arch Ital Biol; 2010 Dec; 148(4):397-403. PubMed ID: 21308653
[TBL] [Abstract][Full Text] [Related]
17. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G
Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA
Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851
[TBL] [Abstract][Full Text] [Related]
19. The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease.
Silva JA; Lorencini M; Peroni LA; De La Hoz CL; Carvalho HF; Stach-Machado DR
J Periodontal Res; 2008 Feb; 43(1):48-54. PubMed ID: 18230106
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of matrix metalloproteinases: implications in clinical neurology.
Romi F; Helgeland G; Gilhus NE
Eur Neurol; 2012; 67(2):121-8. PubMed ID: 22262194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
